Tuesday, April 2, 2013

Indian high court makes landmark verdict on drug patents

Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/epgGCduTtWCilRelCidncVCicNjOmI

April 2, 2013
Increase your exposure at the BIO Business Forum this month in Chicago! Apply to present and pitch your company's story, pipeline, and business objectives to a global audience. Spots are filling fast! Learn more.

The news summaries appearing in BIO SmartBrief are based on original information from news organizations and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The information is not compiled or summarized by BIO. Questions and comments should be directed to SmartBrief at bio@smartbrief.com.

  Today's Top Story 
  Health Care & Policy 
  Company & Financial News 
  • Schizophrenia drug developer gets $18.3M boost
    Intra-Cellular Therapies reported in a regulatory filing that it secured $18.3 million in funding. Those funds will go toward company and clinical development expenses, Chief Financial Officer Larry Hineline said. The New York-based firm is enrolling patients for a midstage trial of ITI-007, its lead drug candidate designed to reduce schizophrenia symptoms. MedCityNews.com (4/1) LinkedInFacebookTwitterEmail this Story
  Food & Agriculture 
  • European Union's biotech crop policies are unnecessary, USTR says
    The Office of the United States Trade Representative released a report criticizing the European Union's policies against U.S. biotech crop imports as the country gears up for free-trade negotiations with the region. The restrictions postpone the approval of new biotech crops in spite of positive evaluations by the European Food Safety Authority, the USTR office said. "These barriers not only harm U.S. ranchers and farmers ... but they also deprive consumers around the world an access to safe, high-quality U.S. food and agricultural goods," acting USTR Demetrios Marantis said. RawStory.com/Agence France-Presse (4/1) LinkedInFacebookTwitterEmail this Story
  Industrial & Environmental 
  • DuPont, USDA team up for sustainable corn-stover collection
    DuPont struck a partnership deal with the Department of Agriculture to create guidelines for how the company's cellulosic ethanol plant in Nevada, Iowa, will obtain corn stover without harming soil quality. The biorefinery, which is due to enter service in 2014, is expected to produce 30 million gallons of ethanol from 375,000 tons of corn stover annually. "Cellulosic advanced biofuel is here and it's here to stay," said Agriculture Secretary Tom Vilsack. SeattlePI.com/The Associated Press (3/29) LinkedInFacebookTwitterEmail this Story
  News from BIO 
  • BIO webinar on reducing your company's energy costs
    BIO and APPI Energy, an energy consulting firm with which BIO has recently aligned through its BIO Business Solutions cost-savings program, can help your company reduce its energy expenses. APPI Energy, the preferred energy consultant of 140 trade associations and chambers of commerce nationwide, provides solutions to reduce electricity and natural gas costs at no risk or obligation to member companies. Join the 30-minute webinar, April 10 at 2 p.m. EDT, to learn about strategies to lower your company’s costs on energy. LinkedInFacebookTwitterEmail this Story
Learn more about BIO ->Conferences  |  Join BIO  |  Media  |  Issues  |  Industry

  SmartQuote 
That which grows fast, withers as rapidly. That which grows slowly, endures."
--Josiah Gilbert Holland,
American writer and poet


LinkedInFacebookTwitterEmail this Story

 
 
This SmartBrief was created for jmabs1@gmail.com
 
Subscriber Tools
     
Update account information | Change e-mail address | Unsubscribe | Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Meryl Harold (202) 407-7828
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent BIO SmartBrief Issues:   Lead Editor:  Tom Parks
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information

No comments: